Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy

C A Greig, N Johns, C Gray, A Macdonald, N A Stephens, R J E Skipworth, M Fallon, L Wall, G M Fox, K C H Fearon

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of this study was to test the safety, tolerability and efficacy of a novel combination of an anabolic β2-agonist and an appetite stimulant in patients with cancer cachexia.
Original languageEnglish
JournalSupportive Care in Cancer
DOIs
Publication statusPublished - 4 Jan 2014

Fingerprint

Dive into the research topics of 'Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy'. Together they form a unique fingerprint.

Cite this